1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > 2016-2020 Emerging In Vitro Diagnostic Technologies and Their Potential Applications

This new report from VPGMarketResearch.com provides assessments of emerging in vitro diagnostic technologies and their potential applications within the following market segments:

- Blood Typing, Grouping, and Screening
- Cancer Diagnostic
- Clinical Chemistry and Immunodiagnostics
- Coagulation Testing
- Hematology and Flow Cytometry
- Microbiology
- Molecular Diagnostics

Technologies analyzed in the report include:

   - Artificial Intelligence
   - Autologous Blood Transfusion/Freezing
   - Automation
   - Biosensors
   - Blood Preservation
   - Chromatography
   - Chromogenic Substrates
   - Chromosome Analysis
   - Diagnostic Imaging
   - Differential Light Scattering
   - Dry Chemistry
   - Flow Cytometry
   - Gel Microdroplets
   - Genetically Engineered Blood Components
   - Immunoassays
   - Information Technology
   - Lasers
   - Liposomes
   - Microcomputers
   - Microdrop Technology
   - Microtitration Plates
   - Molecular Diagnostics
   - Monoclonal and Polyclonal Antibodies
   - Robotics
   - Synthetic Red Cell Substitutes
   - Tandem Mass Spec
   - Two Dimensional Gel Electrophoresis (2-DGE)

Contains 135 pages

Table Of Contents

2016-2020 Emerging In Vitro Diagnostic Technologies and Their Potential Applications
I. INTRODUCTION
II. EXECUTIVE SUMMARY
A. BUSINESS-AS-USUAL SCENARIO
B. ECONOMIC AUSTERITY SCENARIO
C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO
III. CONCLUSIONS AND RECOMMENDATIONS
IV.THE SCENARIOS
A. BUSINESS-AS-USUAL SCENARIO
1. Business Environment
a. Health Care Expenditures
b. Cost-Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
- PPOs
- HMOs
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
- Chronic Illnesses
- Disease Incidence
- Susceptibility to Iatrogenesis
- Multiple Illness Cases
l. Laboratory Regulations
m. The FDA Reform
2. Outlook for the In Vitro Diagnostics Market
a. Government Regulations
b. Centralized Testing
- Hospitals
- Commercial Laboratories
- Blood Banks
- Public Health Laboratories
c. Decentralized Testing
- Personal Testing
- Physician Offices/Group Practices
- Ancillary Hospital Locations
- ERs
- ORs
- ICUs/CCUs
- Cancer Clinics
- Ambulatory Care Centers
- Surgery Centers
- Nursing Homes
- Birth Centers
3. Strategic Implications
a. Testing Patterns
- Test Utilization
- Pre-Admission Testing
- Inpatient Testing
- Outpatient Testing
4. Market Segments
a. Chemistry and Immunoassay
- Introduction
- Future Situation
b. Microbiology and Serology
- Introduction
- Future Situation
c. Hematology and Flow Cytometry
- Introduction
- Future Situation
d. Histology and Cytology
- Introduction
- Future Situation
e. Coagulation
- Introduction
- Future Situation
f. Urinalysis
- Introduction
- Future Situation
g. Blood Banking
- Introduction
- Future Situation
5.Technologies
a. Genomics
- Introduction
- Future Situation
b. Proteomics
- Introduction
- Future Situation
c. DNA Probes
- Introduction
- Future Situation
d. Biochips/Microarrays
- Introduction
- Future Situation
e. Monoclonal Antibodies
- Introduction
- Future Situation
f. Solid Phase Chemistry
- Introduction
- Future Situation
g. Biosensors
- Introduction
- Future Situation
h. Automation and Robotics
- Introduction
- Future Situation
i. Computer-Aided Diagnosis
- Introduction
- Future Situation
6.The New Marketplace
a. Purchasing Influences
b. Marketing Strategies
c. Joint Ventures, Mergers and Licensing
d. Import-Export
e. Potential Market Entrants
f. Who May Not Survive?
B. ECONOMIC AUSTERITY SCENARIO
1. Business Environment
a. Socio-Political Climate
- Cost-Consciousness
- Government Actions
- Three-Tier System
- Health Rationing
- Voucher System
- Health IRA
b. Hospital Closures
c. Hospital Utilization
d. Hospital Reorganization
e. Physician Regulations
f. Wellness Programs
g. Corporate Responses
h. Academic Research
2. Outlook for the In Vitro Diagnostics Market
a. Test Utilization
- Ordering Practices
- Documentation
- Recertification
b.Technology Regulations
c. New Laboratory Ventures
d. Computers
e. Industrial Medicine
f. Insurance Companies
g. Test Volume and Market Size
3. Strategic Implications
a. Testing Patterns
- Pre-Admission Testing
- Inpatient Testing
- Outpatient Testing
b. Market Segments
- Chemistry and Immunoassay
- Microbiology and Serology
- Hematology and Flow Cytometry
- Histology and Cytology
- Coagulation
- Urinalysis
- Blood Banking
c.Technologies
- Genomics
- Proteomics
- DNA Probes
- Biochips/Microarrays
- Monoclonal Antibodies and Immunoassays
- Automation and Robotics
- Solid Phase Chemistry
- Biosensors
- Computer-Aided Diagnosis
d.The New Marketplace
- Purchasing Influences
- Marketing Strategies
- Joint Ventures, Mergers and Licensing
- Import-Export
- Potential Market Entrants
- Who May Not Survive?
C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO
1. Business Environment
a. Political/Regulatory Climate
b. R and D Funding
c. Industry-Government Relationship
d. Industry-University Ventures
e.Technological Environment
f. Testing Decentralization
g. Health Care Expenditures
h. Physician Population
i. Hospital Indicators
2. Outlook for the In Vitro Diagnostics Market
a. Overview
b. Genomics
c. Proteomics
d. DNA and RNA Probes
e. Biochips/Microarrays
f. Monoclonal Antibodies
g. Immunoassays
h. Information Technology
i. Laboratory Automation and Robotics
j. Solid Phase Chemistry
k. Biosensors
l. Holography
m. Pharmaceuticals
3. Strategic Implications
a.Testing Patterns
- Pre-Admission Testing
- Inpatient Testing
- Outpatient Testing
- Test Volume and Market Size
b. Market Segments
- Chemistry and Immunoassay
- Microbiology and Serology
- Hematology and Flow Cytometry
- Histology and Cytology
- Coagulation
- Urinalysis
- Blood Banking
c.The New Marketplace
- Purchasing Influences
- Marketing Strategies
- Joint Ventures, Mergers and Licensing
- Import-Export
- Potential Market Entrants
- Who May Not Survive?
V.APPENDICES: METHODOLOGY
A.The Delphi
B. Cross-Impact Analysis
C. Substitution Modeling
Table of Contents
Executive Summary Table I: Business-As-Usual
Scenario, Growth Areas in Clinical Laboratory
Testing
Executive Summary Table II: Economic Austerity
Scenario, Growth Areas in Clinical Laboratory
Testing
Executive Summary Table III: Technological
Breakthroughs Scenario, Growth Areas in
Clinical Laboratory Testing
Executive Summary Table IV: Market Size by Location
Executive Summary Table V: Market Size by Laboratory
Discipline



List of Tables
Table-1: Business-As-Usual Scenario, Health
Care Costs by Expenditure Type
Table-2: Business-As-Usual Scenario, HMO and PPO
Enrollment
Table-3: Business-As-Usual Scenario, Selected
Hospital Statistics
Table-4: Business-As-Usual Scenario,Total Population
and Physician Demographics
Table-5: Business-As-Usual Scenario,Test Volume
by Location
Table-6: Business-As-Usual Scenario,Test Distribution
by Location
Table-7: Business-As-Usual Scenario, Market Size
by Location
Table-8: Business-As-Usual Scenario,Typical
Pre-Admission Tests
Table-9: Business-As-Usual Scenario,Test Volume
by Laboratory Discipline
Table-10: Business-As-Usual Scenario, Market Size
By Laboratory Discipline
Table-11: Economic Austerity Scenario, Selected
Hospital Statistics
Table-12: Economic Austerity Scenario,
HMO and PPO Enrollment
Table-13: Economic Austerity Scenario,Total Population
and Physician Demographics
Table-14: Economic Austerity Scenario, Major
Categories of Overutilized Tests
Table-15: Economic Austerity Scenario,
Test Volume by Location
Table-16: Economic Austerity Scenario,Test
Distribution by Location
Table-17: Economic Austerity Scenario,
Market Size by Location
Table-18: Economic Austerity Scenario,Timing
Requirements for Selected Laboratory Tests
Table-19: Economic Austerity Scenario,Test Volume
by Laboratory Discipline
Table-20: Economic Austerity Scenario, Market Size
by Laboratory Discipline
Table-21: Technological Breakthroughs Scenario, HMO
and PPO Enrollment
Table-22: Technological Breakthroughs Scenario,Total
Population and Physician Demographics
Table-23: Technological Breakthroughs Scenario,
Selected Hospital Statistics
Table-24: Technological Breakthroughs Scenario,
Test Volume by Location
Table-25: Technological Breakthroughs Scenario,
Test Distribution by Location
Table-26: Technological Breakthroughs Scenario,
Market Size by Location
Table-27: Technological Breakthroughs Scenario,
Test Volume by Laboratory Discipline
Table-28: Technological Breakthroughs Scenario,
Market Size by Laboratory Discipline

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.